Ovid Therapeutics (OVID) - 2025 Q4 - Earnings Call Transcript

Ovid Therapeutics (NasdaqGS:OVID) Q4 2025 Earnings call March 18, 2026 08:30 AM ET Company ParticipantsAlyssa Larios - Senior Associate in Equity ResearchJeffrey Rona - Chief Business and Financial OfficerMeg Alexander - President and CEOVictoria Fort - SVP of Corporate Affairs and Corporate StrategyConference Call ParticipantsFrançois Brisebois - Managing Director in Equity Research and Senior Biotechnology AnalystJay Olson - Managing Director in Equity Research and Senior Biotechnology AnalystLaura Chico ...